NutriSense

Dan Zavaratni and his co-founder recognized an untapped market in consumer health monitoring. Most people thought they were crazy—"why would anyone stab themselves in the arm and let someone else read their data?"—but they believed continuous glucose monitoring could be transformative beyond just type 1 diabetics. Rather than building in stealth, they decided to test demand first.

In September 2019, they created a simple landing page and asked: "Pay $500 and we'll build this for you." They posted in niche Facebook communities—the ketogenic diet groups and Oura Ring communities—where health-conscious early adopters congregated. To their surprise, people actually paid. Armed with real demand signals, Dan's co-founder (an engineer from Acro) "drank a lot of coffee" and shipped the MVP in just three weeks. There was a catch: the launch coincided with iOS 13's new dark mode, which made the app unusable for half the day. They had to solve that quickly, but the validation was clear.

Those initial Facebook group communities became the beachhead. Unlike typical SaaS that cold-emails or runs ads from day one, NutriSense grew organically from passionate health enthusiasts already discussing glucose tracking and biohacking. Customers prepaid $500 for future delivery, giving the company cash to operate without immediate funding. By early 2020—just weeks before COVID—they raised a $250K seed (Techstars + angel) at around 7% dilution.

What worked: (1) going to where customers already gathered (Facebook groups), (2) charging upfront for unbuilt product to validate demand, (3) rapid iteration on core software. The hardware piece proved complex—NutriSense doesn't manufacture; they partner with Dexcom, Abbott, Eversense, and others, paying $40-60 per device. The full unit economics are challenging: gross margins landed around 40-50% (compared to typical SaaS's 80%+) because of device costs, medical provider fees, and dietitian coaching. They initially tried upfront annual prepayments to compress payback period, but eventually shifted to monthly subscriptions to improve affordability.

What didn't: The dark mode launch mishap taught them to anticipate platform changes. They also realized early that going B2B in healthcare was slow, so they doubled down on D2C to prove the value before approaching enterprises.

NutriSense now sits at $3.3M MRR ($39.6M ARR) with 15,000-16,000 paying subscribers and a team of 170 (including 25 engineers and an 18-person marketing team). A year ago, they were at ~$1M MRR, representing a 3x jump in 12 months. Growth came from 13+ simultaneous marketing channels: SEO, Facebook ads, Google ads, Twitter, Quora, Pinterest, and influencer partnerships. Customer LTV-to-CAC ratio is healthy at ~3:1, with CAC averaging $200 and monthly ARPU around $225 ($2,200 annually). Customers stay 7-8 months on average—far longer than the 3 weeks when they launched. They've raised $32M to date (seed, Series A, Series B, Series C rounds) and are positioning for future B2B expansion in healthcare after proving D2C demand.